The University of Southampton
University of Southampton Institutional Repository

Interpatient variability in rates of asthma progression: can genetics provide an answer?

Interpatient variability in rates of asthma progression: can genetics provide an answer?
Interpatient variability in rates of asthma progression: can genetics provide an answer?
Asthma is a heterogeneous disorder with a variable natural history. In children 3 patterns of the natural history of asthma have been described: early onset but transient, persistent, and later onset, with only the former leading to persistent asthma later in childhood. In adults a range of different asthma phenotypes differing in their environmental, inflammatory, and prognostic characteristics have also been described. These extend beyond allergic (extrinsic) and nonallergic (intrinsic) asthma to include persistent airflow obstruction and accelerated decrease in lung function over time. Asthma progression can be defined as the change in an individual's phenotype along a continuum ranging from nonasthmatic to asthmatic and subsequent development of severe chronic disease. It is clear that for prevention of asthma progression in patients, there is a need for both better understanding of the pathophysiology of asthma and identification of predictors of progression. Interpatient genetic variability has been shown to affect multiple facets of asthma progression, including increased susceptibility to atopy and subsequent asthma, progression to severe disease, and modification of the response to treatment. Thus genetic testing might provide a means for predicting the likely progression of an individual along the continuum, allowing targeting of preventative treatment. However, the prospect of the use of genetic information in clinical practice raises important social and ethical issues that will need to be addressed before genetic testing can be used to inform the preventative treatment of patients to prevent the development of progression of asthma in individuals.
asthma, asthma progression, genetics, genetic testing
0091-6749
573-579
Holloway, John W.
4bbd77e6-c095-445d-a36b-a50a72f6fe1a
Yang, Ian A.
f55f0532-ce8f-424c-af64-f8052139f2f2
Holgate, Stephen T.
2e7c17a9-6796-436e-8772-1fe6d2ac5edc
Holloway, John W.
4bbd77e6-c095-445d-a36b-a50a72f6fe1a
Yang, Ian A.
f55f0532-ce8f-424c-af64-f8052139f2f2
Holgate, Stephen T.
2e7c17a9-6796-436e-8772-1fe6d2ac5edc

Holloway, John W., Yang, Ian A. and Holgate, Stephen T. (2008) Interpatient variability in rates of asthma progression: can genetics provide an answer? Journal of Allergy and Clinical Immunology, 121 (3), 573-579. (doi:10.1016/j.jaci.2008.01.007).

Record type: Article

Abstract

Asthma is a heterogeneous disorder with a variable natural history. In children 3 patterns of the natural history of asthma have been described: early onset but transient, persistent, and later onset, with only the former leading to persistent asthma later in childhood. In adults a range of different asthma phenotypes differing in their environmental, inflammatory, and prognostic characteristics have also been described. These extend beyond allergic (extrinsic) and nonallergic (intrinsic) asthma to include persistent airflow obstruction and accelerated decrease in lung function over time. Asthma progression can be defined as the change in an individual's phenotype along a continuum ranging from nonasthmatic to asthmatic and subsequent development of severe chronic disease. It is clear that for prevention of asthma progression in patients, there is a need for both better understanding of the pathophysiology of asthma and identification of predictors of progression. Interpatient genetic variability has been shown to affect multiple facets of asthma progression, including increased susceptibility to atopy and subsequent asthma, progression to severe disease, and modification of the response to treatment. Thus genetic testing might provide a means for predicting the likely progression of an individual along the continuum, allowing targeting of preventative treatment. However, the prospect of the use of genetic information in clinical practice raises important social and ethical issues that will need to be addressed before genetic testing can be used to inform the preventative treatment of patients to prevent the development of progression of asthma in individuals.

This record has no associated files available for download.

More information

Published date: March 2008
Keywords: asthma, asthma progression, genetics, genetic testing

Identifiers

Local EPrints ID: 59329
URI: http://eprints.soton.ac.uk/id/eprint/59329
ISSN: 0091-6749
PURE UUID: 09b4e5eb-bb70-44d1-bb32-28e2b2987d85
ORCID for John W. Holloway: ORCID iD orcid.org/0000-0001-9998-0464

Catalogue record

Date deposited: 19 Sep 2008
Last modified: 16 Mar 2024 02:57

Export record

Altmetrics

Contributors

Author: Ian A. Yang

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×